Trial intelligence / Profile preview

MAGraine: Magnesium vs Conventional Therapy in Acute Migraine

NCT05967442Phase 3Completed

Sponsor
Wake Forest University Health Sciences
Start
Aug 2019
Primary completion
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of magnesium sulfate in migraine, Headache, sponsored by Wake Forest University Health Sciences. Started Aug 2019; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

migraineHeadache

Beyond the preview

Go deeper on NCT05967442.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05967442.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call